Clinical Trial Update: Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD) [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated pantoprazole for efficacy and safety in infants with symptomatic gastroesophageal reflux disease and has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2010-01-07